Influence of sulfasalazine and olsalamine on colonic epithelial cell folate content in patients with ulcerative colitis

Inflammatory Bowel Diseases

Volumn 2, Issue 3, 1996, Pages 163-167

  Meenan, John ^a,c   O'Hallinan, Eileen ^a   Scott, John ^b   Weir, Donald G ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Colitis; Dysplasia; Epithelium; Folate

Indexed keywords

EID: 27644548687     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020302     Document Type: Article

References (25)

1. Ekbom A, Helmick C, Zack M, Adami H. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
2. Vemulpalli R, Lance P. Cancer surveillance in ulcerative colitis: more of the same or progress? Gastroenterology 1994;107:1196-9.
3. Lashner BA, Heidenrich PA, Su GL, Kane SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis: a case control study. Gastroenterology 1989;97:255-9.
4. Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 1993;119:549-54.
5. Butterworth CE, Hatch KD, Gore H, Mueller H, Krumdieck CL. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 1982;35:73-82.
6. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willet WC. Alcohol, low-methionine-low-folate diets and risk of colon cancer in man. J Natl Cancer Inst 1995;87:265-73.
7. Heimburger DC, Alexander CB, Birch R, Butterworth CE, Bailley WC, Krumdieck CL. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. JAMA 1988;259:1525-30.
8. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nature Genetic 1994;7:536-40.
9. Ribieras S, Song-Wang X, Martin V, Lointier P, Frappart L, Dante R. Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes 11p and 17p. J Cell Biochem 1994; 56:86-96.
10. Pang Y, Norihisa Y, Benjamin D, Kantor RRS, Young HA. Interferon gamma gene expression in human B-cell lines: induction by interleukin 2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood 1992;80:724-32.
11. Butterworth CE, Hatch KD, Macaluso M, Cole P, Sauberlich HE, Soong S, Borst M, Baker VV. Folate deficiency and cervical dysplasia. JAMA 1992;267:528-33.
12. Meenan J, O'Hallinan E, Lynch S, Molloy A, McPartlan J, Scott J, Weir DG. The folate status of gastrointestinal epithelial cells is not predicted by serum and red cell folate levels in replete individuals. Gut 1996;38:410-13.
13. O'Broin S, Kelleher B. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol 1992; 45:344-7.
14. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami H. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 1994;107:117-20.
15. Franklin JL, Rosenberg IH. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (azulfidine). Gastroenterology 1973;64:517-25.
16. Davis AE, Patterson F, Crouch R. The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model. Br J Cancer 1992;66:777-80.
17. Sharon P, Drab EA, Linder JS, Weidman SW, Sabesin SM, Rubin DB. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution: comparison with olsalazine, 5-aminosalicylic acid and sulfapyridine. J Lab Clin Med 1992;119:99-107.
18. Zimmerman J. Folic acid transport in organ-cultured mucosa of human intestine: evidence for distinct carriers. Gastroenterology 1990;99:964-72.
19. Fiedler L, Rubin P, Korelitz B, Sachar D, Present D. Does folate (F) supplementation really protect from dysplasia and cancer in ulcerative colitis (UC)? A case control study. Gastroenterology 1993;104:A700.
20. Tominaga M, Iida M, Aoyagi K, Kohrogi N, Matsui T, Fujishima M. Red cell folate concentrations in patients with Crohn's disease on parenteral nutrition. Postgrad Med J 1989;65:818-20.
21. Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Etseve M, Gonzalez-Huix F, Gassull MA. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989;84:744-8.
22. Selhub S, Dhar GJ, Rosenberg IH. Inhibition of folate enzymes by sulfasalazine. J Clin Invest 1978;61:221-4.
23. Baum CL, Selhub J, Rosenberg IH. Antifolate actions of sulfasalazine on intact lymphocytes. J Lab Clin Med 1981; 97:779-85.
24. Kim YI, Fawaz K, Knox T, Arora S, Lee YM, Paiva L, Mason JB. Lower colonic mucosal folate concentrations in patients with adenomatous polyps compared to those with hyperplastic polyps: possible implications for the development of colorectal carcinoma. Gastroenterology 1984;106: A402.
25. Cravo M, Fidalgo P, Pereira AD, Gouveia-Oliveira A, Nobre Leitao C, Costa Mira F. Folate supplementation increases the degree of DNA methylation in patients with colonic neoplasms. Gastroenterology 1993;104:A394.